Laurolinium acetate

This classification denotes an anti-infective agent with the molecular formula C22H35N2.C2H3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier R01EZP92PU, chemically known as quinolinium, 4-amino-1-dodecyl-2-methyl-, acetate (9ci) but generally known as laurolinium acetate, which bears US NIH Compound Identifier 67354. European Medicines Agency schedules Laurolinium acetate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08416MIG. The term LAUROLINIUM ACETATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). Most nations schedule laurolinium acetate under HS 29334990 and SITC 51575. As of Q4 2014, LAUROLINIUM ACETATE remains the US FDA Preferred Term for this commodity. Laurolinium acetate bears US NLM identifiers UMLS ID C2825363 and NCI Concept Code C80858. SMILES: OC(=O)C.[n]1(CCCCCCCCCCCC)c2c(c(N)cc1C)cccc2.